Jun 22, 2020
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
Jun 22, 2020
Therapeutic Use of CBD Continues to Spread
Jun 19, 2020
Dupixent® (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Jun 19, 2020
Full results from EMPERIAL exercise ability trials presented
Jun 18, 2020
Innovent Announces First Patient Dosed in A Phase 1b/2 Clinical Trial of IBI362, a Dual GLP-1 and Glucagon Receptor Agonist, in China
Jun 18, 2020
Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions
Jun 18, 2020
RINVOQ(TM) (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis
Jun 18, 2020
Global Alopecia Treatment Market (2019 to 2026) - by Drug Type, Indication, and Distribution Channel
Jun 18, 2020
Nephrologists Are Hesitant to Fully Embrace Janssen's INVOKANA Despite Being the First and Only SGLT2 Inhibitor with an FDA Indication to Treat Diabetic Kidney Disease
Jun 17, 2020
LifePlus previews its breakthrough smartwatch for people with prediabetes, hypertension & other chronic conditions
Jun 17, 2020
Antidiabetics Market Demand to Hit USD 130B by 2026: Global Market Insights, Inc.
Jun 17, 2020
Perrigo Partners With Kazmira LLC To Enter CBD Market Through A Two-Phased, Science-Based Approach
Jun 16, 2020
New Capture the Fracture® Partnership Aims for 25% Reduction in the Incidence of Hip and Vertebral Fractures Due to Osteoporosis by 2025
Jun 16, 2020
Whole in One: Treat Enlarged Pores and Give Your Skin an Overall Boost
Jun 16, 2020
New Data from Diabetes Prevention Program Outcomes Study Shows Persistent Reduction of Type 2 Diabetes Development Over 22-Year Average Follow-Up
Jun 16, 2020
International Study of More Than 8,000 People Showed Ertugliflozin Does Not Increase Risk of Cardiac Events
Jun 16, 2020
$3.27 Billion Retinal Surgery Devices Market Assessment 2020-2026 - COVID-19 Updated
Jun 15, 2020
Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients
Jun 15, 2020
Data Presented at the 2020 ADA Scientific Sessions Show that Patients Treated with Cirius Therapeutics' MSDC-0602K Showed Improved Insulin Handling
Jun 15, 2020
Dompé Presents Phase II Clinical Trial Results for Ladarixin in New-Onset Type 1 Diabetes at the American Diabetes Association's Scientific Sessions